Impact of atrial fibrillation-induced tachycardiomyopathy in patients undergoing pulmonary vein isolation

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 4093-4097

  Calvo, Naiara ^c   Bisbal, Felipe ^c   Guiu, Esther ^c   Ramos, Pablo ^c   Nadal, Mercé ^c   Tolosana, Jose María ^c   Arbelo, Elena ^c   Berruezo, Antonio ^c   Sitges, Marta ^c   Brugada, Josep ^c   Mont, Lluís ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c NONE

Author keywords

Atrial fibrillation; Catheter Ablation; Heart Failure; Tachycardiomyopathy

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CATHETER ABLATION; CHILD; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; RISK FACTOR; SCHOOL CHILD; TACHYCARDIA INDUCED CARDIOMYOPATHY; THERAPY EFFECT; ATRIAL FIBRILLATION; ECHOGRAPHY; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; PULMONARY VEIN; SURGERY; TACHYCARDIA; TREATMENT OUTCOME; TRENDS;

ADULT; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PULMONARY VEINS; TACHYCARDIA; TREATMENT OUTCOME;

EID: 84886299103     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.017     Document Type: Article

References (36)

1. W.B. Kannel, and A.J. Belanger Epidemiology of heart failure Am Heart J 121 1991 951 957
2. M.G. Bourassa, O. Gurne, and S.I. Bangdiwala Natural history and patterns of current practice in heart failure. The studies of left ventricular dysfunction (SOLVD) investigators J Am Coll Cardiol 22 1993 14A 19A
3. S. Yusuf, T. Thom, and R.D. Abbott Changes in hypertension treatment and in congestive heart failure mortality in the United States Hypertension 13 1989 I74 I79
4. W.H. Maisel, and L.W. Stevenson Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy Am J Cardiol 91 2003 2D 8D
5. E.J. Benjamin, D. Levy, S.M. Vaziri, R.B. D'Agostino, A.J. Belanger, and P.A. Wolf Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study JAMA 271 1994 840 844
6. C.J. McLaran, B.J. Gersh, D.D. Sugrue, S.C. Hammill, J.B. Seward, and D.R. Holmes Jr. Tachycardia induced myocardial dysfunction. A reversible phenomenon? Br Heart J 53 1985 323 327
7. D.L. Packer, G.H. Bardy, and S.J. Worley Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction Am J Cardiol 57 1986 563 570
8. E. Phillips, and S.A. Levine Auricular fibrillation without other evidence of heart disease; a cause of reversible heart failure Am J Med 7 1949 478 489
9. M. Grogan, H.C. Smith, B.J. Gersh, and D.L. Wood Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy Am J Cardiol 69 1992 1570 1573
10. G. Fenelon, W. Wijns, E. Andries, and P. Brugada Tachycardiomyopathy: mechanisms and clinical implications Pacing Clin Electrophysiol 19 1996 95 106
11. F. Anselme, N. Boyle, and M. Josephson Incessant fascicular tachycardia: a cause of arrhythmia induced cardiomyopathy Pacing Clin Electrophysiol 21 1998 760 763
12. E. Umana, C.A. Solares, and M.A. Alpert Tachycardia-induced cardiomyopathy Am J Med 114 2003 51 55
13. J.S. Shinbane, M.A. Wood, D.N. Jensen, K.A. Ellenbogen, A.P. Fitzpatrick, and M.M. Scheinman Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies J Am Coll Cardiol 29 1997 709 715
14. J.R. Kieny, A. Sacrez, and A. Facello Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy Eur Heart J 13 1992 1290 1295
15. A.T. Gosselink, H.J. Crijns, and M.P. van den Berg Functional capacity before and after cardioversion of atrial fibrillation: a controlled study Br Heart J 72 1994 161 166
16. S.H. Hohnloser, K.H. Kuck, and J. Lilienthal Rhythm or rate control in atrial fibrillation - pharmacological intervention in atrial fibrillation (PIAF): a randomised trial Lancet 356 2000 1789 1794
17. M. Brignole, C. Menozzi, and L. Gianfranchi Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study Circulation 98 1998 953 960
18. P. Richardson, W. McKenna, and M. Bristow Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies Circulation 93 1996 841 842
19. H. Calkins, K.H. Kuck, and R. Cappato 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design Europace 14 2012 528 606
20. A. Natale, A. Raviele, and T. Arentz Venice chart international consensus document on atrial fibrillation ablation J Cardiovasc Electrophysiol 18 2007 560 580
21. N. Dagres, G. Hindricks, and H. Kottkamp Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern? J Cardiovasc Electrophysiol 20 2009 1014 1019
22. V. Fuster 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation J Am Coll Cardiol 57 2011 e101
23. T. De Potter, A. Berruezo, and L. Mont Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation Europace 12 2010 24 29
24. M.S. Chen, N.F. Marrouche, and Y. Khaykin Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function J Am Coll Cardiol 43 2004 1004 1009
25. L.F. Hsu, P. Jais, and P. Sanders Catheter ablation for atrial fibrillation in congestive heart failure N Eng J Med 351 2004 2373 2383
26. C. Tondo, M. Mantica, and G. Russo Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function Pacing Clin Electrophysiol 29 2006 962 970
27. P.J. Gentlesk, W.H. Sauer, and E.P. Gerstenfeld Reversal of left ventricular dysfunction following ablation of atrial fibrillation J Cardiovasc Electrophysiol 18 2007 9 14
28. M.N. Khan, P. Jais, and J. Cummings Pulmonary-vein isolation for atrial fibrillation in patients with heart failure N Engl J Med 359 2008 1778 1785
29. B.A. Lutomsky, T. Rostock, and A. Koops Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging Europace 10 2008 593 599
30. K. Nademanee, M.C. Schwab, and E.M. Kosar Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation J Am Coll Cardiol 51 2008 843 849
31. S.B. Wilton, A. Fundytus, and W.A. Ghali Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction Am J Cardiol 106 2010 1284 1291
32. A. Berruezo, D. Tamborero, and L. Mont Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation Eur Heart J 28 2007 836 841
33. K. Dickstein, P.E. Vardas, and A. Auricchio 2010 focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Eur Heart J 31 2010 2677 2687
34. A. Cheema, J. Dong, and D. Dalal Long-term safety and efficacy of circumferential ablation with pulmonary vein isolation J Cardiovasc Electrophysiol 17 2006 1080 1085
35. C. Pappone, S. Rosanio, and G. Augello Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study J Am Coll Cardiol 42 2003 185 197
36. R. Cappato, H. Calkins, and S.A. Chen Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation Circ Arrhythm Electrophysiol 3 2010 32 38